Jun 3, 2026Effective9999999995-26-001874
All companies
Trade Geovax Labs Inc424B4Dec 22, 2025
GeoVax Labs, Inc. S-1 registration of securities filed May 26, 2026 (S-1)
Geovax Labs Inc
GOVXPublicArchived
Public / ArchivedUnited States(Nasdaq)Best valuation $3.82M1 market
Public listing
Listed· Nasdaq· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: lifecycle-news, sec-edgar, sec-harvest, nasdaq
IPO Calendar · NasdaqIPO
GOVXPrice
$1.32
24h
-1.49%
Valuation
$3.82M
24h volume
$712.84K
Type
IPO
Trade Geovax Labs IncNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 1h ago
Geovax Labs Inc IPO public float & lock-up
Public float and locked shares extracted from Geovax Labs Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.
Total shares (FD)
43.3M
Public float
—
Locked
—
IPO raise
—
Next unlock
—
Needs review: Could not extract a detailed lock-up release schedule.
Financials
UnprofitableFrom SEC filings, latest FY ending Dec 31, 2025 · CIK 0000832489.
Revenue · -37.06% YoY
$2.49M
Net income
-$21.46M
Gross margin
—
Cash
$3.09M
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.49M | $3.95M | $0 | $81.53K | $385.5K |
| Operating income | -$21.64M | -$25.14M | -$26.74M | -$14.03M | -$18.75M |
| Net income | -$21.46M | -$24.99M | -$25.97M | -$14.02M | -$18.57M |
| R&D expense | $18.12M | $23.71M | $20.72M | $9.12M | $15.55M |
| Cash & equivalents | $3.09M | $5.51M | $6.45M | $27.61M | $11.42M |
| Total assets | $6.34M | $8.16M | $9.28M | $31.35M | $11.8M |
| Total liabilities | $2.52M | $3.11M | — | $4.75M | $7.44M |
| Shareholders' equity | $3.83M | $5.05M | $5.76M | $26.6M | $4.36M |
About Geovax Labs Inc
Geovax Labs Inc is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.
What the company does
- Operates with a business profile defined by its products, services, customers, and operating execution.
- Its durable fundamentals depend on demand for its products or services, margin structure, competitive position, management execution, and capital discipline.
- Primary company filings and official materials are the best source for detailed information about revenue drivers, risk factors, and operating strategy.
Business profile
Geovax Labs Inc should be evaluated through its durable business model: what it sells, who it serves, how it generates revenue, and how efficiently it can scale.
SEC IPO filings
EffectiveEDGAR filings resolved from GOVX / CIK 0000832489.
S-1FORM S-1
May 26, 2026Filed0001437749-26-018320
Apr 21, 2026Effective9999999995-26-001278
Apr 21, 2026Effective9999999995-26-001277
Apr 17, 2026Effective9999999995-26-001237
Apr 17, 2026Effective9999999995-26-001232
Apr 17, 2026Effective9999999995-26-001231
Apr 17, 2026Effective9999999995-26-001230
Apr 17, 2026Effective9999999995-26-001227
CORRESPfilename1.htm
Apr 17, 2026SEC correspondence0001437749-26-012657
CORRESPfilename1.htm
Apr 17, 2026SEC correspondence0001437749-26-012656
UPLOADfilename1.pdf
Apr 17, 2026SEC correspondence0000000000-26-003924
Latest Geovax Labs Inc IPO news
Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.
Last10K.comMay 26, 2026IPO filing
GeoVax Labs, Inc. submitted an S-1 registration statement to the SEC on May 26, 2026 (accession 0001437749-26-018320).
Geovax Labs Inc IPO — frequently asked questions
- When did Geovax Labs Inc go public?
- Geovax Labs Inc has already gone public and now trades publicly on Nasdaq under the ticker GOVX.
- Can I buy Geovax Labs Inc stock?
- Yes — Geovax Labs Inc is publicly traded on Nasdaq as GOVX. You can follow its live price, valuation and post-IPO performance above.
- What is Geovax Labs Inc's valuation?
- Geovax Labs Inc's most recent valuation tracked here is $3.82M, derived from live market prices.